Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Decentralized Clinical Trials Industry 2026-2032: Regional Challenges and Opportunities in Emerging Markets

globenewswire.com

Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Decentralized Clinical Trials Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering.

Decentralized clinical trials are redefining how organizations design and execute research by leveraging digital processes, remote participation, and interoperable systems. In this evolving market, global sponsors seek more inclusive participant engagement while meeting complex regulatory and operational standards.

Market Snapshot: Decentralized Clinical Trials Market

The Decentralized Clinical Trials Market continues its upward trajectory, with expansion from USD 9.87 billion in 2025 to USD 10.40 billion in 2026. With a projected compound annual growth rate (CAGR) of 6.60%, the market is set to reach USD 15.45 billion by 2032. This growth is fueled by a widespread move toward digital protocols, flexible study models, and integrated technologies that streamline both evidence collection and trial operations.

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Why This Report Matters

Key Attributes

Key Topics Covered

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. Market Size & Growth Trends

3.4. Market Share Analysis, 2025

3.5. FPNV Positioning Matrix, 2025

3.6. New Revenue Opportunities

3.7. Next-Generation Business Models

3.8. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Porter's Five Forces Analysis

4.4. PESTLE Analysis

4.5. Market Outlook

4.5.1. Near-Term Market Outlook (0-2 Years)

4.5.2. Medium-Term Market Outlook (3-5 Years)

4.5.3. Long-Term Market Outlook (5-10 Years)

4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Decentralized Clinical Trials Market, by Component

8.1. Services

8.1.1. Data Management

8.1.2. Logistics

8.1.3. Patient Recruitment

8.2. Technology Solutions

8.2.1. eCOA/ePRO

8.2.2. Study Supply Management

8.2.3. Telemedicine

8.2.4. Wearables & Sensors

9. Decentralized Clinical Trials Market, by Trial Phase

9.1. Phase I

9.2. Phase II

9.3. Phase III

9.4. Phase IV

10. Decentralized Clinical Trials Market, by Therapeutic Area

10.1. Cardiovascular

10.2. CNS

10.3. Endocrine & Metabolism

10.4. Oncology

11. Decentralized Clinical Trials Market, by Sponsor Type

11.1. Biotech Companies

11.2. Contract Research Organizations

11.3. Pharmaceutical Companies

12. Decentralized Clinical Trials Market, by Deployment Model

12.1. Fully Decentralized

12.2. Hybrid

12.3. Site-Led

13. Decentralized Clinical Trials Market, by Region

13.1. Americas

13.1.1. North America

13.1.2. Latin America

13.2. Europe, Middle East & Africa

13.2.1. Europe

13.2.2. Middle East

13.2.3. Africa

13.3. Asia-Pacific

14. Decentralized Clinical Trials Market, by Group

14.1. ASEAN

14.2. GCC

14.3. European Union

14.4. BRICS

14.5. G7

14.6. NATO

15. Decentralized Clinical Trials Market, by Country

15.1. United States

15.2. Canada

15.3. Mexico

15.4. Brazil

15.5. United Kingdom

15.6. Germany

15.7. France

15.8. Russia

15.9. Italy

15.10. Spain

15.11. China

15.12. India

15.13. Japan

15.14. Australia

15.15. South Korea

16. United States Decentralized Clinical Trials Market

17. China Decentralized Clinical Trials Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025

18.1.1. Concentration Ratio (CR)

18.1.2. Herfindahl Hirschman Index (HHI)

18.2. Recent Developments & Impact Analysis, 2025

18.3. Product Portfolio Analysis, 2025

18.4. Benchmarking Analysis, 2025

18.5. Bayer AG

18.6. ICON plc

18.7. IQVIA Holdings Inc.

18.8. Laboratory Corporation of America Holdings

18.9. Medable, Inc.

18.10. Medidata Solutions, Inc.

18.11. Parexel International Corporation

18.12. PPD, Inc.

18.13. PRA Health Sciences, Inc.

18.14. Science 37, Inc.

18.15. THREAD Research, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/g21nci

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment